Edaravone suspension for oral administration | Patent Application Number 17213501

17213501

Not Appealed

Publication NumberUS 20210212990 A1

Filled DateMar 26, 2021

Priority DateNov 1, 2019

Inventor/ApplicantsTetsuo Hayama
Munetomo Matsuda
Tomoyuki OMURA
Tomohiro Takahashi
Tomoyuki Omura
Tadashi MIYAZAWA
Tetsuo HAYAMA
Tomohiro TAKAHASHI
Munetomo MATSUDA
Kouji Hayashi
Kouji HAYASHI
Tadashi Miyazawa

ExaminesCHANNAVAJJALA, LAKSHMI SARADA

Art Unit1611

Technology Center1600

Assignments

Mitsubishi Chemical Group Corporation

Current

Mitsubishi Chemical Group Corporation

Original

Law Firm

You must be logged in to view

Attorneys

Subscription-Only

View Concierge Program

See the invalidated claims, subscribe to our Concierge Program.

View Concierge Program

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.